Английская Википедия:Hexahydrocannabiphorol
Шаблон:Short description Шаблон:Infobox drug
Hexahydrocannabiphorol (HHCP, sometimes mistakenly referred to as hexahydroxycannabiphorol) is a semi-synthetic cannabinoid derivative which has been marketed since around 2021.[1][2] It is believed to be made from the hydrogenation of tetrahydrocannabiphorol (THCP). THCP is only reported as a trace component of cannabis in 2019.[3] HHCP was studied by Roger Adams as early as 1942.[4]
Legality
The legal status of hexahydrocannabinol and derivatives varies between countries, leading to widespread sale in some jurisdictions in Europe and the US.
In France, HHCP was banned in 2023.[5]
In Japan, Japanese Health Ministry announced that six synthetic cannabinoids with structures similar to HHCH, including HHCP, were to be banned from 6 January 2024.[6]
HHCP was banned in Slovakia as of 13 January 2024.Шаблон:Citation needed
See also
References
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Hexahydrocannabinol (HHC) and related substances. European Monitoring Centre for Drugs and Drug Addiction, 2023
- ↑ https://pubs.acs.org/doi/abs/10.1021/ja01255a061
- ↑ Шаблон:Cite web
- ↑ https://english.kyodonews.net/news/2023/12/20893a7e69cb-japan-decides-to-ban-more-cannabinoids-after-gummies-sicken-people.html